UFP Technologies, Inc. acquired CI Medical Inc.

UFP Technologies, Inc. (UFPT) completed the acquisition of CI Medical Inc. on September 7, 2026. The company's stock has seen a 5-day change of 288.79 USD, a 1st Jan change of +0.79%, and a year-to-date change of +30.07%.

Original reporting
Published Sep 7, 2026, 6:05 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 8, 2026, 12:10 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$UFPT
Bullish
high confidence
Mentioned
$UFPT
Relevance
7/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$UFPTBullishHigh
01

Why it matters

The acquisition expands UFP's product offerings in the medical device space, potentially boosting revenue and market share.

02

Market read

Primary M&A news for UFPT; likely to move the stock on the day of announcement.

03

What to watch

No disclosed purchase price; financing method and balance‑sheet impact remain unclear.

Relevance 7/10Novelty 8/10Timing: pre-market

Background

UFP Technologies (NasdaqCM:UFPT) announced the completion of its acquisition of CI Medical Inc. on September 7, 2026.

Company-level read

Ticker impact

$UFPTBullishHigh confidence
Context

UFP Technologies completed the acquisition of CI Medical Inc., announced on Sep 7, 2026.

Expected impact

Short-term upside as investors price in synergies; medium-term depends on integration execution.

Evidence & confidence

M&A announcements are typically priced in quickly; no valuation disclosed but the transaction is material for a mid‑cap.

Market effects

Adds a medical device line to UFP's manufacturing portfolio, may pressure peers in the med‑tech sector.

U.S. market focus; limited regional spillover.

Modest; primarily affects UFP and its niche market.

Counterpoint

Integration risks could outweigh synergies, leading to a pullback after the initial rally.

Key entities

  • UFP Technologies, Inc.

    Acquirer, listed on NasdaqCM under UFPT.

  • CI Medical Inc.

    Target of the acquisition, not publicly listed.

Related articles

$UFPTMedAI 8/10

UFP Technologies (UFPT) Q2 2026 Earnings Call Transcript

UFP Technologies (UFPT) reported Q2 2026 net sales of $174 million, up 15.1%, with organic sales growth of 12.4%. Adjusted EPS rose 16.8% to $2.92 and gross margin increased to 29.3%. Adjusted EBITDA was $36.4 million. Management cited MedTech strength, low leverage under 1x, and an acquisition pipeline of 5 to 10 opportunities.

$UFPTMedAI 8/10

Why UFP Technologies Stock Is Skyrocketing Today

UFP Technologies (NASDAQ: UFPT) shares rose about 24% by 2 p.m. ET after the company reported strong Q2 results. UFP said sales grew 15%, adjusted EPS rose 17%, and revenue increased 15% to its five largest customers. The company also reported 12% organic growth and 20% growth in its core medtech unit, and is monitoring tuck-in acquisitions.

$UFPTMedAI 8/10

Why Is UFP Technologies (UFPT) Stock Soaring Today

UFP Technologies (UFPT) shares rose 18.5% after the company reported Q2 2026 results that beat Wall Street. Revenue increased 15.1% to $174 million, adjusted EPS was $2.92 versus $2.56 expected, and adjusted EBITDA was $36.39 million, 11.5% above forecasts, according to the company.